ITOVEBI (inavolisib) recall in Canada: Risk of life-threatening ketoacidosis
In plain language
This recall involves ITOVEBI (inavolisib) tablets, 3 mg and 9 mg, sold in Canada. It's being recalled because it may cause life-threatening ketoacidosis, especially in diabetic patients. Patients should consult their healthcare professional if they have questions or concerns about this information.
What to do
- Stop taking the product and seek immediate medical attention if you experience signs of ketoacidosis.
- Consult with your healthcare professional if you have any questions or concerns.
- Ensure blood glucose levels are well-controlled and stable before and during treatment.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
ITOVEBI (inavolisib) tablets
Why this matters
Risk of life-threatening ketoacidosis
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of life-threatening ketoacidosis
What should consumers do?
Stop taking the product and seek immediate medical attention if you experience signs of ketoacidosis. Consult with your healthcare professional if you have any questions or concerns. Ensure blood glucose levels are well-controlled and stable before and during treatment.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of life-threatening ketoacidosis
When was this product recalled?
This product was recalled on October 9, 2025.
Is the ITOVEBI brand affected by this recall?
Yes, ITOVEBI products are affected by this recall. This recall involves ITOVEBI (inavolisib) tablets, 3 mg and 9 mg, sold in Canada. It's being recalled because it may cause life-threatening ketoacidosis, especially in diabetic patients. Patients should consult their healthcare professional if they have questions or concerns about this information.